ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
IBSA
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
Introducing Merional 150IU, commonly known as hMG, a powerful solution designed to combat infertility in women. This hormone-based medication, also referred to as Menotropin, plays a vital role in stimulating egg production for women facing ovarian failure. Sourced from the urine of postmenopausal women, Merional 150IU contains elevated levels of crucial hormones such as follicle stimulating hormone (FSH) and lutropin hormone (LH). The injection is conveniently administered intramuscularly, ensuring effective delivery.
While using Merional 150IU Injection, it?s essential to be aware of potential side effects. Users may experience headaches, mood fluctuations, fatigue, weight gain, localized swelling at the injection site, breast enlargement, and tenderness. Additionally, abdominal discomfort may arise due to ovarian hyperstimulation syndrome (OHSS), a condition that can occur with excessive egg production. It?s also important to consider the possibility of conceiving multiples if this was not the intended outcome. Always consult your healthcare provider prior to beginning this medication, especially if you have any of the following conditions:
- Allergy to menotropins or gonadotropins
- Vaginal bleeding
- Ovarian cysts
Dosage of Merional 150IU is personalized to meet the unique needs of each patient. For those aiming to increase the likelihood of conception, it is recommended to attempt pregnancy within 12 to 36 hours after receiving the injection. If your initial treatment cycle does not yield success, it?s advisable to evaluate your options. Should ovulation not occur after three cycles, consider discussing further treatment alternatives with your doctor concerning Merional 150IU.